Table 1 Clinicopathologic characteristics of IPO5 expression in CRC patients
|
Clinicopathological Variables All cases | N 100 |
High expression 53 |
Low Expression 47 | X 2 | P |
|---|---|---|---|---|---|
| Age (years) | |||||
| ≤ 60 | 48 | 26 | 22 | 0.050 | 0.49 |
| > 60 | 52 | 27 | 25 | 0 | |
| Gender | |||||
| Male | 56 | 28 | 28 | 0.460 | |
| Female | 44 | 25 | 19 | 0.549 | |
| Tumor size (cm) | |||||
| ≤ 4.75 | 49 | 21 | 28 | 3.968 | |
| > 4.75 | 51 | 32 | 19 | 0.036 | |
| Differentiation | |||||
| Well | 20 | 7 | 13 | 7.647 | |
| Moderate | 61 | 30 | 31 | 0.020 | |
| Poor | 19 | 16 | 3 | ||
| Serosal invasion | |||||
| Yes | 40 | 20 | 20 | 0.241 | |
| No | 60 | 33 | 27 | 0.387 | |
| Lymph metastasis | |||||
| Yes | 45 | 30 | 15 | 10.389 | |
| No | 55 | 23 | 32 | 0.006 | |
| TNM classification | |||||
| I–II | 65 | 29 | 36 | 10.585 | |
| III–IV | 35 | 24 | 11 | 0.014 | |